On Aug. 6, 2017, Sue Sisley, M.D., sent a letter to Secretary of Veterans Affairs David Shulkin to request that he stop a Phoenix hospital’s obstruction of the first clinical trial to study the effects of medical cannabis in the treatment of post-traumatic stress disorder in military veterans.
Tag Archives: Clinical Trial
If just a single clinical trial works in favor of Cara Therapeutics, it could regain everything it’s recently lost and possibly hit a $1 billion market cap.
Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.
Medical marijuana remains the safest investment route — if you’re forced to choose one — so here’s a brief rundown of the cannabinoid-based drugs working their way through clinical and preclinical trials.
In this World of Cannabis interview, watch Caroline Cahill, Managing Editor of Marijuana Industry News, interview Ryan Brown, Co-founder of Tetra Bio Pharma.
NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.
Sue Sisley, M.D., is leading the way in studying medical marijuana and post-traumatic stress disorder. In her talk, “Coping With PTSD,” hear Sisley discuss the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans.
On Feb. 6, 2017, the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans dispensed medical marijuana to its first veteran at the Scottsdale Research Institute in Phoenix.
PHOENIX, Ariz., Feb. 7, 2017 /Weed Wire/ — On February 6, 2017, the first participant in the first-ever clinical trial of smoked marijuana (cannabis) for post-traumatic stress disorder (PTSD) in U.S. veterans received cannabis at the Scottsdale Research Institute (SRI) in Phoenix, Ariz.
On Oct. 2, 2016, Maureen Leehey, MD, discussed the potential of cannabis in treating Parkinson’s disease at the 3rd Annual Parkinson’s Disease Symposium at the University of Colorado Movement Disorders Center.
While the debate over the efficacy of medical marijuana continues, there is a growing body of evidence that suggests it may be helpful in treating patients suffering from intractable seizures.
The first Health Canada-approved clinical trial for medical cannabis has started patient recruitment to determine the pain-relieving characteristics of vaporized cannabis.
NEW YORK, June 24, 2015 /PRNewswire/ — Columbia Care LLC, one of the nation’s leading medical marijuana companies, announced a research agreement today with the Icahn School of Medicine at Mount Sinai, an internationally acclaimed research institution in New York City, to advance the science and safe practice of medical marijuana therapy. The agreement funds ongoing retrospective research already underway. The two institutions are also discussing the formation of the New York State Medical Marijuana Research Network (MMRN), which will develop a registry research project to explore the safety and efficacy of medical marijuana in treating a range of clinical conditions.
Science crowdfunding startup Walacea is helping Madrid’s MedicalCannabis Bike Tour to raise the final €85,000 it needs to conduct an independent clinical trial into the effect of cannabinoids on brain tumours.
The Land of Lincoln’s medical marijuana program has been off to a slow start—with not one patient yet receiving treatment from the pilot program that went into effect Jan. 1, 2014.